Session 5: Sylvester O’Halloran Prize Session
AB069. NR4A1 agonist CsnB may affect macrophage cells primarily within colorectal tumours in order to reduce pro-inflammatory response
Mesentery and Peritoneum
2020;
4:
AB069
(02 March 2020)
Session 5: Sylvester O’Halloran Prize Session
AB068. An observational study, identifying, measuring and quantifying the interference of intraoperative distractions within the general surgery operating theatre
Mesentery and Peritoneum
2020;
4:
AB068
(02 March 2020)
Session 5: Sylvester O’Halloran Prize Session
AB067. Frailty and emergency abdominal surgery: a systematic review
Mesentery and Peritoneum
2020;
4:
AB067
(02 March 2020)
Session 5: Sylvester O’Halloran Prize Session
AB066. Elucidating the circulating and tumour-specific immune populations in a cohort of colon cancer patients
Mesentery and Peritoneum
2020;
4:
AB066
(02 March 2020)
Session 5: Sylvester O’Halloran Prize Session
AB065. First line chemotherapy regimens used in oesophageal adenocarcinoma promote immune dysfunction and enhance a cancer stem-like phenotype: potential implications for chemoimmuno resistance and novel multi-modal treatment regimens
Mesentery and Peritoneum
2020;
4:
AB065
(02 March 2020)
Session 5: Sylvester O’Halloran Prize Session
AB064. Defining the genomic landscape of mucinous rectal cancer
Mesentery and Peritoneum
2020;
4:
AB064
(02 March 2020)
Session 4: General I
AB063. Primary hormonal therapy for women diagnosed with breast cancer ≥70
Mesentery and Peritoneum
2020;
4:
AB063
(02 March 2020)
Session 4: General I
AB062. Triple assessment breast clinics: the value of clinical core biopsies
Mesentery and Peritoneum
2020;
4:
AB062
(02 March 2020)
Session 4: General I
AB061. Transversus abdominis plane block in laparoscopic bariatric surgery—a systematic review and meta-analysis of randomised controlled trials
Mesentery and Peritoneum
2020;
4:
AB061
(02 March 2020)
Session 4: General I
AB060. Is it time to revise the Siewert classification of cancer of the esophagogastric junction?
Mesentery and Peritoneum
2020;
4:
AB060
(02 March 2020)
Session 4: General I
AB059. The incidence and oncological outcomes of oesophageal cancer in Ireland—a 5-year retrospective review
Mesentery and Peritoneum
2020;
4:
AB059
(02 March 2020)
Session 4: General I
AB058. Enhanced recovery after bariatric surgery: clinical outcomes in a tertiary referral bariatric centre
Mesentery and Peritoneum
2020;
4:
AB058
(02 March 2020)
Session 4: General I
AB057. Anatomical photo-documentation during oesophagogastroduodenoscopy (OGD): a snapshot in time
Mesentery and Peritoneum
2020;
4:
AB057
(02 March 2020)
Session 4: General I
AB056. Feasibility and safety of gastric electrical stimulation in the management of medically refractory gastroparesis: a case series
Mesentery and Peritoneum
2020;
4:
AB056
(02 March 2020)
Session 4: General I
AB055. Options in bariatric surgery: modelled decision analysis supports Roux-en-Y gastric bypass as the treatment of choice when type 2 diabetes is present
Mesentery and Peritoneum
2020;
4:
AB055
(02 March 2020)
Session 4: General I
AB054. Normal mucosa: oesophageal biopsies for all?—biopsy practices fall short of recommendations in excluding eosinophilic oesophagitis in patients with dysphagia and normal endoscopy
Mesentery and Peritoneum
2020;
4:
AB054
(02 March 2020)
Session 3: Colorectal
AB053. Perioperative administration of Ac2-26 loaded nanoparticles facilitates postoperative recovery in a murine model for intestinal anastomotic healing during acute colitis
Mesentery and Peritoneum
2020;
4:
AB053
(02 March 2020)
Session 3: Colorectal
AB052. Fistulotomy with or without marsupialization for simple fistula-in-ano—a systematic review and meta-analysis
Mesentery and Peritoneum
2020;
4:
AB052
(02 March 2020)
Session 3: Colorectal
AB051. Laparoscopic versus ultrasound-guided transversus abdominis plane block in laparoscopic colorectal surgery—a systematic review and meta-analysis
Mesentery and Peritoneum
2020;
4:
AB051
(02 March 2020)
Session 3: Colorectal
AB050. Transverse versus extended colectomy for transverse colon cancer: a systematic review and meta-analysis
Mesentery and Peritoneum
2020;
4:
AB050
(02 March 2020)
Session 3: Colorectal
AB049. Defunctioning stoma in the management of malignant bowel obstruction
Mesentery and Peritoneum
2020;
4:
AB049
(02 March 2020)
Session 3: Colorectal
AB048. Implementation of an enhanced recovery protocol in a complex colorectal patient cohort in Galway University Hospital (GUH)
Mesentery and Peritoneum
2020;
4:
AB048
(02 March 2020)
Session 3: Colorectal
AB047. Audit of enhanced recovery after surgery (ERAS) protocol for elective colorectal surgical procedures
Mesentery and Peritoneum
2020;
4:
AB047
(02 March 2020)
Session 3: Colorectal
AB046. Lymph node yield is not a reliable prognostic marker in anterior resection and abdominoperineal resection following neoadjuvant therapy for rectal cancer
Mesentery and Peritoneum
2020;
4:
AB046
(02 March 2020)
Session 3: Colorectal
AB045. Impact of genitourinary & infectious disease (GUIDE) involvement and anal cancer survival outcomes
Mesentery and Peritoneum
2020;
4:
AB045
(02 March 2020)
Session 3: Colorectal
AB044. A comparative study of proctectomy rates following the commencement of a trans-anal minimally invasive surgery programme
Mesentery and Peritoneum
2020;
4:
AB044
(02 March 2020)
Session 3: Colorectal
AB043. Lymphocyte-CRP ratio (LCR) as a possible biomarker for anastomotic leak in rectal cancer patients
Mesentery and Peritoneum
2020;
4:
AB043
(02 March 2020)
Session 2: Vascular
AB042. Evaluation of the influence of wall shear stress features on endothelial cell phenotypes
Mesentery and Peritoneum
2020;
4:
AB042
(02 March 2020)
Session 2: Vascular
AB041. In-hospital outcomes of asymptomatic descending thoracic aortic aneurysm intervention
Mesentery and Peritoneum
2020;
4:
AB041
(02 March 2020)
Session 2: Vascular
AB040. Re-intervention and malignancy development post-endovascular aneurysm repair—fifteen-year experience of aneurysm repair
Mesentery and Peritoneum
2020;
4:
AB040
(02 March 2020)